Astellas Pharma | 4503 - Nettoeinkommen

Aktienkurs
2,608.00
Täglich Wechseln
-49.50 -1.86%
Monatlich
8.69%
Jährlich
89.60%
Q2 Prognose
2,495.20




Nettoeinkommen Veränderung Datum
Astellas Pharma JPY 100.38B 21.17B 2025-12
Chugai Pharma JPY 128.41B 17.2B 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Kyowa Hakko Kirin JPY 34.44B 18.16B 2025-12
M3 JPY 18.94B 8.07B 2025-12
Otsuka Holdings JPY 65.49B 58.64B 2025-12
Shionogi JPY 74.68B 30.5B 2025-12
Sumitomo Dainippon JPY 87.65B 76.45B 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Terumo JPY 32.65B 2.4B 2025-12